K. Harrington‐Brock

发表

Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations

D. DeMarini, P. Poorman-Allen, K. Funasaka, 2003, Environmental and molecular mutagenesis.

Loss of P53 heterozygosity is not responsible for the small colony thymidine kinase mutant phenotype in L5178Y mouse lymphoma cells.

L. S. Clark, M. Moore, L. Sargent, 2004, Mutagenesis.

Mutan tFrequenc yan dMutationa lSpectr ai nth eT kand Hpr tGene so fN-Ethyl-N-nitrosourea-Treate dMouse Lymphom aCells

K. Harrington‐Brock, 2002 .

Issues for conducting the microtiter version of the mouse lymphoma thymidine kinase (tk) assay and a critical review of data generated in a collaborative trial using the microtiter method.

M. Moore, J. Cole, K. Harrington‐Brock, 1999, Mutagenesis.

Failure to adequately use positive control data leads to poor quality mouse lymphoma data assessments.

M. Moore, D. Collard, K. Harrington‐Brock, 1999, Mutagenesis.

Relative genotoxic potency of arsenic and its methylated metabolites.

K. Harrington-Brock, M. Moore, C. Doerr, 1997, Mutation research.

Effects of arsenic exposure on the frequency of HPRT-mutant lymphocytes in a population of copper roasters in Antofagasta, Chile: a pilot study.

J. Fuscoe, R. McConnell, K. Harrington-Brock, 1999, Mutation research.

Biological effects of arsenic exposure—integration of in vitro genotoxicity data with human biomarker data

K. Harrington-Brock, M. Moore, M. Cabrera, 1997 .

Genotoxicity in mouse lymphoma cells of chemicals capable of Michael addition.

J. Rabinowitz, M. Moore, K. Dearfield, 1991, Mutagenesis.

Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene.

M M Moore, M. Moore, K Harrington-Brock, 2000, Environmental health perspectives.

Mutagenicity of three disinfection by-products: di- and trichloroacetic acid and chloral hydrate in L5178Y/TK +/- (-)3.7.2C mouse lymphoma cells.

M. Moore, C. Doerr, K. Harrington‐Brock, 1998, Mutation research.

Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci.

M. Moore, K. Dearfield, C. Doerr, 1989, Mutagenesis.

V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.

J. Fuscoe, R. Albertini, J. Nicklas, 1992, Mutation research.

Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies.

I. M. Jones, J. Fuscoe, M. Moore, 1998, Mutation research.

Analysis of the genotoxicity of nine acrylate/methacrylate compounds in L5178Y mouse lymphoma cells.

M. Moore, K. Dearfield, C. Doerr, 1989, Mutagenesis.

Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro.

M. Moore, D. DeMarini, J. Allen, 1990, Mutagenesis.

Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells.

M. Moore, C. Doerr, K. Harrington‐Brock, 1989, Mutation research.

Mutant frequency and mutational spectra in the Tk and Hprt genes of N‐ethyl‐N‐nitrosourea‐treated mouse lymphoma cells †

Tao Chen, Tao Chen, M. Moore, 2002, Environmental and molecular mutagenesis.

Bromate induces loss of heterozygosity in the thymidine kinase gene of L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.

Tao Chen, D. Collard, K. Harrington‐Brock, 2003, Mutation research.

Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes.

J. Fuscoe, M. Moore, L. Zimmerman, 1992, Mutation research.

Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000

Julie Clements, Masamitsu Honma, Wolfgang Muster, 2002, Environmental and molecular mutagenesis.

Genotoxicity of three pyridine compounds to L5178Y mouse lymphoma cells.

M. Moore, K. Dearfield, C. Doerr, 1993, Mutation research.

Mutagenicity and clastogenicity of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in L5178Y/TK+/(-)-3.7.2C mouse lymphoma cells.

M. Moore, C. Doerr, K. Harrington‐Brock, 1995, Mutation research.

Genotoxicity of 2-amino-6-N-hydroxyadenine (AHA) to mouse lymphoma and CHO cells.

M. Moore, J. Hozier, C. Doerr, 1991, Mutation research.

Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.

Tao Chen, K. Harrington-Brock, M. Moore, 2002, Mutagenesis.

Comparison of mutagenicity results for nine compounds evaluated at the hgprt locus in the standard and suspension CHO assays.

K. Harrington-Brock, M. Moore, K. Dearfield, 1991, Mutagenesis.

Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.

J. Barrett, L. S. Clark, D. W. Hart, 1998, Mutagenesis.

The mouse lymphoma assay in the wake of ICH4--where are we now?

M M Moore, M. Moore, J. Cole, 1999, Mutagenesis.

Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancers.

J. Fuscoe, M. Moore, L. Zimmerman, 1994, Carcinogenesis.

Analysis of the genotoxicity of anthraquinone dyes in the mouse lymphoma assay.

M. Cimino, C. Doerr, Lisa Parker, 1991, Mutagenesis.

Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup report

W. Muster, K. Harrington-Brock, M. Moore, 2000, Environmental and molecular mutagenesis.